Abstract

The term iontophoresis typically refers to the transfer of charged substances through a biological membrane under the influence of an electric field (1). This technique is far from new, Leduc having shown nearly 100 years ago that the technique could be used to deliver active drugs across mammalian skin in vivo (2,3). Since then, iontophoresis has been variously used to administer pilocarpine in the diagnosis of cystic fibrosis, to treat hyperhidrosis of palms and soles (tap water iontophoresis), to induce local anaesthesia in the skin and in the external ear canal, to aid penetration of fluoride ions in dentistry, and so on (2-4). Yet it was only 20 years ago, following the initial success of passive transdermal drug delivery, that iontophoresis received attention as a way to expand the range of drugs that could be administered via the skin (5). At the same time, it was fully appreciated (6) that the permeation of water, neutral and zwitterionic compounds could also be enhanced by iontophoresis, thereby expanding its potential applications. This observation, and the recognition of the skin as a permselective membrane, focused attention on convective solvent flow (electroosmosis) as a second mechanism of electrotransport (7). The advantages of iontophoresis as a controlled and versatile drug administration technique were soon identified for peptides and drugs for the treatment of Parkinson’s disease, migraine, pain, etc. Within the last 10 years, the symmetrical nature of iontophoresis (i.e., that the passage of current across the skin causes ions to move into and out of the membrane at the same time) has led to its application as a noninvasive method of extracting endogenous substances (8). This so-called reverse iontophoresis procedure is exemplified by the Glucowatch Biographer® recently approved by the FDA for glucose monitoring.

Original languageEnglish
Title of host publicationTransdermal Drug Delivery
Subtitle of host publicationSecond Edition, Revised and Expanded
EditorsRichard H.Guy, Jonathan Hadgraft
Place of PublicationBoca Roca, US
PublisherCRC Press
Pages199-225
Number of pages27
Edition2
ISBN (Electronic)9780203909683
ISBN (Print)9780824708610
Publication statusPublished - 29 Oct 2002

ASJC Scopus subject areas

  • Medicine(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Delgado-Charro, M. B., & Guy, R. H. (2002). Iontophoresis: Applications in drug delivery and noninvasive monitoring. In R. H.Guy, & J. Hadgraft (Eds.), Transdermal Drug Delivery: Second Edition, Revised and Expanded (2 ed., pp. 199-225). Boca Roca, US: CRC Press.

Iontophoresis : Applications in drug delivery and noninvasive monitoring. / Delgado-Charro, M. Begoña; Guy, Richard H.

Transdermal Drug Delivery: Second Edition, Revised and Expanded. ed. / Richard H.Guy; Jonathan Hadgraft. 2. ed. Boca Roca, US : CRC Press, 2002. p. 199-225.

Research output: Chapter in Book/Report/Conference proceedingChapter

Delgado-Charro, MB & Guy, RH 2002, Iontophoresis: Applications in drug delivery and noninvasive monitoring. in R H.Guy & J Hadgraft (eds), Transdermal Drug Delivery: Second Edition, Revised and Expanded. 2 edn, CRC Press, Boca Roca, US, pp. 199-225.
Delgado-Charro MB, Guy RH. Iontophoresis: Applications in drug delivery and noninvasive monitoring. In H.Guy R, Hadgraft J, editors, Transdermal Drug Delivery: Second Edition, Revised and Expanded. 2 ed. Boca Roca, US: CRC Press. 2002. p. 199-225
Delgado-Charro, M. Begoña ; Guy, Richard H. / Iontophoresis : Applications in drug delivery and noninvasive monitoring. Transdermal Drug Delivery: Second Edition, Revised and Expanded. editor / Richard H.Guy ; Jonathan Hadgraft. 2. ed. Boca Roca, US : CRC Press, 2002. pp. 199-225
@inbook{dda93954490843f4a581ea7f212cba90,
title = "Iontophoresis: Applications in drug delivery and noninvasive monitoring",
abstract = "The term iontophoresis typically refers to the transfer of charged substances through a biological membrane under the influence of an electric field (1). This technique is far from new, Leduc having shown nearly 100 years ago that the technique could be used to deliver active drugs across mammalian skin in vivo (2,3). Since then, iontophoresis has been variously used to administer pilocarpine in the diagnosis of cystic fibrosis, to treat hyperhidrosis of palms and soles (tap water iontophoresis), to induce local anaesthesia in the skin and in the external ear canal, to aid penetration of fluoride ions in dentistry, and so on (2-4). Yet it was only 20 years ago, following the initial success of passive transdermal drug delivery, that iontophoresis received attention as a way to expand the range of drugs that could be administered via the skin (5). At the same time, it was fully appreciated (6) that the permeation of water, neutral and zwitterionic compounds could also be enhanced by iontophoresis, thereby expanding its potential applications. This observation, and the recognition of the skin as a permselective membrane, focused attention on convective solvent flow (electroosmosis) as a second mechanism of electrotransport (7). The advantages of iontophoresis as a controlled and versatile drug administration technique were soon identified for peptides and drugs for the treatment of Parkinson’s disease, migraine, pain, etc. Within the last 10 years, the symmetrical nature of iontophoresis (i.e., that the passage of current across the skin causes ions to move into and out of the membrane at the same time) has led to its application as a noninvasive method of extracting endogenous substances (8). This so-called reverse iontophoresis procedure is exemplified by the Glucowatch Biographer{\circledR} recently approved by the FDA for glucose monitoring.",
author = "Delgado-Charro, {M. Bego{\~n}a} and Guy, {Richard H.}",
year = "2002",
month = "10",
day = "29",
language = "English",
isbn = "9780824708610",
pages = "199--225",
editor = "Richard H.Guy and Hadgraft, {Jonathan }",
booktitle = "Transdermal Drug Delivery",
publisher = "CRC Press",
address = "USA United States",
edition = "2",

}

TY - CHAP

T1 - Iontophoresis

T2 - Applications in drug delivery and noninvasive monitoring

AU - Delgado-Charro, M. Begoña

AU - Guy, Richard H.

PY - 2002/10/29

Y1 - 2002/10/29

N2 - The term iontophoresis typically refers to the transfer of charged substances through a biological membrane under the influence of an electric field (1). This technique is far from new, Leduc having shown nearly 100 years ago that the technique could be used to deliver active drugs across mammalian skin in vivo (2,3). Since then, iontophoresis has been variously used to administer pilocarpine in the diagnosis of cystic fibrosis, to treat hyperhidrosis of palms and soles (tap water iontophoresis), to induce local anaesthesia in the skin and in the external ear canal, to aid penetration of fluoride ions in dentistry, and so on (2-4). Yet it was only 20 years ago, following the initial success of passive transdermal drug delivery, that iontophoresis received attention as a way to expand the range of drugs that could be administered via the skin (5). At the same time, it was fully appreciated (6) that the permeation of water, neutral and zwitterionic compounds could also be enhanced by iontophoresis, thereby expanding its potential applications. This observation, and the recognition of the skin as a permselective membrane, focused attention on convective solvent flow (electroosmosis) as a second mechanism of electrotransport (7). The advantages of iontophoresis as a controlled and versatile drug administration technique were soon identified for peptides and drugs for the treatment of Parkinson’s disease, migraine, pain, etc. Within the last 10 years, the symmetrical nature of iontophoresis (i.e., that the passage of current across the skin causes ions to move into and out of the membrane at the same time) has led to its application as a noninvasive method of extracting endogenous substances (8). This so-called reverse iontophoresis procedure is exemplified by the Glucowatch Biographer® recently approved by the FDA for glucose monitoring.

AB - The term iontophoresis typically refers to the transfer of charged substances through a biological membrane under the influence of an electric field (1). This technique is far from new, Leduc having shown nearly 100 years ago that the technique could be used to deliver active drugs across mammalian skin in vivo (2,3). Since then, iontophoresis has been variously used to administer pilocarpine in the diagnosis of cystic fibrosis, to treat hyperhidrosis of palms and soles (tap water iontophoresis), to induce local anaesthesia in the skin and in the external ear canal, to aid penetration of fluoride ions in dentistry, and so on (2-4). Yet it was only 20 years ago, following the initial success of passive transdermal drug delivery, that iontophoresis received attention as a way to expand the range of drugs that could be administered via the skin (5). At the same time, it was fully appreciated (6) that the permeation of water, neutral and zwitterionic compounds could also be enhanced by iontophoresis, thereby expanding its potential applications. This observation, and the recognition of the skin as a permselective membrane, focused attention on convective solvent flow (electroosmosis) as a second mechanism of electrotransport (7). The advantages of iontophoresis as a controlled and versatile drug administration technique were soon identified for peptides and drugs for the treatment of Parkinson’s disease, migraine, pain, etc. Within the last 10 years, the symmetrical nature of iontophoresis (i.e., that the passage of current across the skin causes ions to move into and out of the membrane at the same time) has led to its application as a noninvasive method of extracting endogenous substances (8). This so-called reverse iontophoresis procedure is exemplified by the Glucowatch Biographer® recently approved by the FDA for glucose monitoring.

UR - http://www.scopus.com/inward/record.url?scp=85056976245&partnerID=8YFLogxK

M3 - Chapter

SN - 9780824708610

SP - 199

EP - 225

BT - Transdermal Drug Delivery

A2 - H.Guy, Richard

A2 - Hadgraft, Jonathan

PB - CRC Press

CY - Boca Roca, US

ER -